Literature DB >> 33627701

Population structure and genetic diversity of non-O157 Shiga toxin-producing Escherichia coli (STEC) clinical isolates from Michigan.

Heather M Blankenship1,2, Rebekah E Mosci1, Stephen Dietrich2, Elizabeth Burgess2, Jason Wholehan2, Karen McWilliams3, Karen Pietrzen3, Scott Benko3, Ted Gatesy3, James T Rudrik2, Marty Soehnlen2, Shannon D Manning4.   

Abstract

Non-O157 STEC are increasingly linked to foodborne infections, yet little is known about the diversity and molecular epidemiology across locations. Herein, we used whole genome sequencing to examine genetic variation in 894 isolates collected from Michigan patients between 2001 and 2018. In all, 67 serotypes representing 69 multilocus sequence types were identified. Serotype diversity increased from an average of four (2001-2006) to 17 (2008-2018) serotypes per year. The top six serogroups reported nationally caused > 60% of infections in 16 of the 18 years; serogroups O111 and O45 were associated with hospitalization as were age ≥ 65 years, diarrhea with blood and female sex. Phylogenetic analyses of seven multilocus sequence typing (MLST) loci identified three clades as well as evidence of parallel evolution and recombination. Most (95.5%) isolates belonged to one clade, which could be further differentiated into seven subclades comprising isolates with varying virulence gene profiles and serotypes. No association was observed between specific clades and the epidemiological data, suggesting that serogroup- and serotype-specific associations are more important predictors of disease outcomes than lineages defined by MLST. Molecular epidemiological studies of non-O157 STEC are important to enhance understanding of circulating strain distributions and traits, genetic variation, and factors that may impact disease risk and severity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33627701      PMCID: PMC7904848          DOI: 10.1038/s41598-021-83775-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

2.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Molecular characterization reveals three distinct clonal groups among clinical shiga toxin-producing Escherichia coli strains of serogroup O103.

Authors:  Atsushi Iguchi; Sunao Iyoda; Makoto Ohnishi
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

4.  Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories.

Authors:  L Hannah Gould; Cheryl Bopp; Nancy Strockbine; Robyn Atkinson; Vickie Baselski; Barbara Body; Roberta Carey; Claudia Crandall; Sharon Hurd; Ray Kaplan; Marguerite Neill; Shari Shea; Patricia Somsel; Melissa Tobin-D'Angelo; Patricia M Griffin; Peter Gerner-Smidt
Journal:  MMWR Recomm Rep       Date:  2009-10-16

5.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Molecular subtyping and genetic analysis of the enterohemolysin gene (ehxA) from Shiga toxin-producing escherichia coli and atypical enteropathogenic E. coli.

Authors:  Adrian L Cookson; Jenny Bennett; Fiona Thomson-Carter; Graeme T Attwood
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

7.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.

Authors:  Erin B Hedican; Carlota Medus; John M Besser; Billie A Juni; Bonnie Koziol; Charlott Taylor; Kirk E Smith
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

9.  Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA.

Authors:  R E Luna-Gierke; P M Griffin; L H Gould; K Herman; C A Bopp; N Strockbine; R K Mody
Journal:  Epidemiol Infect       Date:  2014-01-07       Impact factor: 4.434

10.  Genetic Diversity of Intimin Gene of Atypical Enteropathogenic Escherichia coli Isolated from Human, Animals and Raw Meats in China.

Authors:  Yanmei Xu; Xiangning Bai; Ailan Zhao; Wang Zhang; Pengbin Ba; Kai Liu; Yujuan Jin; Hong Wang; Qiusheng Guo; Hui Sun; Jianguo Xu; Yanwen Xiong
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more
  1 in total

1.  Antibiotic Susceptibility Profiles and Frequency of Resistance Genes in Clinical Shiga Toxin-Producing Escherichia coli Isolates from Michigan over a 14-Year Period.

Authors:  Sanjana Mukherjee; Heather M Blankenship; Jose A Rodrigues; Rebekah E Mosci; James T Rudrik; Shannon D Manning
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.